Quantitative structure–activity relationships (QSARs) in CYP3A4 inhibitors: The importance of lipophilic character and hydrogen bonding

By Lewis David F.V.   Lake Brian G.   Dickins Maurice  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 21, Iss. 2, 2006-04 ,pp. : 127-132

Informa Healthcare

Access to resources Recommend Favorite

A new depsidone of Lobaria pulmonaria with acetylcholinesterase inhibition activity

By Pejin Boris   Tommonaro Giuseppina  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 28, Iss. 4, 2013-08 ,pp. : 876-878

Informa Healthcare

Access to resources Recommend Favorite

5-Nitro-2,6-dioxohexahydro-4-pyrimidinecarboxamides: synthesis, in vitro antimycobacterial activity, cytotoxicity, and isocitrate lyase inhibition studies

By Sriram Dharmarajan   Yogeeswari Perumal   Senthilkumar Palaniappan   Naidu Geetanjali   Bhat Pritesh  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 25, Iss. 6, 2010-12 ,pp. : 765-772

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of CaT1 Channel Activity by a Noncompetitive IP₃ Antagonist

By Vassilev P.M.   Peng J-B.   Johnson J.   Hediger M.A.   Brown E.M.  

Biochemical and Biophysical Research Communications, Vol. 280, Iss. 1, 2001-01 ,pp. : 145-150

Elsevier

Access to resources Recommend Favorite

Acetylcholinesterase/Butyrylcholinesterase inhibition activity of some new carbacylamidophosphate deriviatives

By Gholivand Khodayar   Abdollahi Mohammad   Mojahed Fresia   Alizadehgan Ahlam Madani   Dehghan Gholamreza  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 24, Iss. 2, 2009-04 ,pp. : 566-576

Informa Healthcare

Access to resources Recommend Favorite